ExecPay

Christopher Rovaldi

Overview2022

Overview

Christopher Rovaldi received $4M in total compensation, including $435K in salary, at Keros Therapeutics in 2022.

Source: SEC filing on April 24, 2023.
Rovaldi's 2022 pay

Related executives

We found four more executives who work or worked at Keros Therapeutics.

Jasbir Seehra

Keros Therapeutics

Chief Executive Officer

4

Simon MBBS

Keros Therapeutics

Chief Medical Officer

1

Keith Regnante

Keros Therapeutics

Chief Financial Officer

2

Jennifer Lachey

Keros Therapeutics

Chief Scientific Officer

3

News

You may also like

Keros Therapeutics